Is cognitive impairment in multiple sclerosis reversible?

被引：0
作者：
Giovannoni, Gavin [1 ]
Hawkes, Chris [1 ]
Levy, Michael [1 ]
Waubant, Emmanuelle [1 ]
机构：
[1] Barts & London Queen Marys Sch Med & Dent, Blizard Inst, 4 Newark St, London E1 2AT, England
来源：
MULTIPLE SCLEROSIS AND RELATED DISORDERS | 2018年 / 23卷
关键词：
Multiple sclerosis; Cognitive impairment; Sickness behaviour;
D O I：
10.1016/j.msard.2018.07.007
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：A1 / A1
页数：1
相关论文
共 9 条
[1]   Cytokine-induced sickness behaviour: a neuroimmune response to activation of innate immunity [J].
Dantzer, R .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2004, 500 (1-3) :399-411
[2]   Does focal inflammation have an impact on cognition in multiple sclerosis? An MRI study [J].
Fenu, Giuseppe ;
Arru, Mauro ;
Lorefice, Lorena ;
Frau, Jessica ;
Coghe, Giancarlo ;
Fronza, Marzia ;
Loi, Luciano ;
Barracciu, Maria Antonietta ;
Marrosu, Maria Giovanna ;
Cocco, Eleonora .
MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2018, 23 :83-87
[3]   Time and brain health both matter in multiple sclerosis [J].
Giovannoni, Gavin .
MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2016, 9 :S1-S3
[4]   The association between cognitive impairment and quality of life in patients with early multiple sclerosis [J].
Glanz, Bonnie I. ;
Healy, Brian C. ;
Rintell, David J. ;
Jaffin, Sharon K. ;
Bakshi, Rohit ;
Weiner, Howard L. .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2010, 290 (1-2) :75-79
[5]   The representation of inflammatory signals in the brain - a model for subjective fatigue in multiple sclerosis [J].
Hanken, Katrin ;
Eling, Paul ;
Hildebrandt, Helmut .
FRONTIERS IN NEUROLOGY, 2014, 5
[6]   Economic evidence in multiple sclerosis: A review [J].
Kobelt G. .
The European Journal of Health Economics, 2004, 5 (Suppl 1) :S54-S62
[7]   Natalizumab Significantly Improves Cognitive Impairment over Three Years in MS: Pattern of Disability Progression and Preliminary MRI Findings [J].
Mattioli, Flavia ;
Stampatori, Chiara ;
Bellomi, Fabio ;
Scarpazza, Cristina ;
Capra, Ruggero .
PLOS ONE, 2015, 10 (07)
[8]   COGNITIVE DYSFUNCTION IN MULTIPLE-SCLEROSIS .2. IMPACT ON EMPLOYMENT AND SOCIAL FUNCTIONING [J].
RAO, SM ;
LEO, GJ ;
ELLINGTON, L ;
NAUERTZ, T ;
BERNARDIN, L ;
UNVERZAGT, F .
NEUROLOGY, 1991, 41 (05) :692-696
[9]   Cognitive function did not improve after initiation of natalizumab treatment in relapsing-remitting multiple sclerosis. A prospective one-year dual control group study [J].
Sundgren, M. ;
Piehl, Fredrik ;
Wahlin, Ake ;
Brismar, Tom .
MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2016, 10 :36-43
1